The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary

By  

Current Cardiology Reviews, Vol. 4, Iss. 4, 2008-11 ,pp. : 293-299

Bentham Science Publishers

Access to resources Recommend Favorite

Update on Glycoprotein IIb/IIIa: Role in Primary Coronary Intervention

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 9, Iss. 2, 2011-01 ,pp. : 106-112

Bentham Science Publishers

Access to resources Recommend Favorite

Successful recanalization of an occluded coronary artery by percutaneous coronary intervention, systemic administration of tirofiban, a glycoprotein IIb/IIIa inhibitor, and intracoronary thrombolysis with alteplase

By Meyners W.  

Zeitschrift für Kardiologie, Vol. 93, Iss. 5, 2004-05 ,pp. : 407-412

Springer Publishing Company

Access to resources Recommend Favorite

Intracoronary Use of GP IIb/IIIa Inhibitors in Percutaneous Coronary Interventions

By  

Current Vascular Pharmacology, Vol. 10, Iss. 4, 2012-07 ,pp. : 448-453

Bentham Science Publishers

Access to resources Recommend Favorite

Glycoprotein IIb/IIIa receptor antagonists in acute myocardial infarction and primary coronary stenting: Not always effective

By Banai Shmuel   Medina Aharon   Keren Andre  

International Journal of Cardiovascular Interventions, Vol. 3, Iss. 4, 2000-12 ,pp. : 241-243

Informa Healthcare

Access to resources Recommend Favorite